Combination of Vancomycin and β-Lactam Therapy for Methicillin-ResistantStaphylococcus aureusBacteremia: A Pilot Multicenter Randomized Controlled Trial (Q57763098)

From Wikidata

Jump to navigation Jump to search

article by Joshua S. Davis et al published 8 September 2015 in Clinical Infectious Diseases

Language	Label	Description	Also known as
English	Combination of Vancomycin and β-Lactam Therapy for Methicillin-ResistantStaphylococcus aureusBacteremia: A Pilot Multicenter Randomized Controlled Trial	article by Joshua S. Davis et al published 8 September 2015 in Clinical Infectious Diseases

Statements

scholarly article

0 references

Combination of Vancomycin and β-Lactam Therapy for Methicillin-ResistantStaphylococcus aureusBacteremia: A Pilot Multicenter Randomized Controlled Trial (English)

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

randomized controlled trial

1 reference

based on heuristic

inferred from title

author name string

Joshua S. Davis

1

0 references

Archana Sud

2

0 references

Matthew V. N. O'Sullivan

3

0 references

James O. Robinson

4

0 references

Patricia E. Ferguson

5

0 references

Hong Foo

6

0 references

Sebastiaan J. van Hal

7

0 references

Anna P. Ralph

8

0 references

Benjamin P. Howden

9

0 references

Paula M. Binks

10

0 references

Adrienne Kirby

11

0 references

Steven Y. C. Tong

12

0 references

language of work or name

0 references

publication date

8 September 2015

0 references

Clinical Infectious Diseases

0 references

62

0 references

2

0 references

173-180

0 references

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Vancomycin: does it still have a role as an antistaphylococcal agent?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

The pharmacokinetic and pharmacodynamic properties of vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus infections.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the "seesaw effect": Taking advantage of the back door left open?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

β-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Diagnosis and management of Staphylococcus aureus bacteraemia.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Prospective genotyping of hospital-acquired methicillin-resistant Staphylococcus aureus isolates by use of a novel, highly discriminatory binary typing system

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV808

21 January 2018

Identifiers

10.1093/CID/CIV808

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57763098&oldid=1565721309"